AAAAAA

   
Results: 1-13 |
Results: 13
NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED RENAL-FAILURE - A BRIEF REVIEW OF THE ROLE OF CYCLOOXYGENASE ISOFORMS
Authors: VENTURINI CM ISAKSON P NEEDLEMAN P
Citation: Cm. Venturini et al., NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED RENAL-FAILURE - A BRIEF REVIEW OF THE ROLE OF CYCLOOXYGENASE ISOFORMS, Current opinion in nephrology and hypertension, 7(1), 1998, pp. 79-82
PRECLINICAL PHARMACOLOGY OF CELECOXIB AND DEMONSTRATION OF SUPERIOR GI SAFETY COMPARED WITH NSAIDS IN DOGS
Authors: PAULSON S MAZIASZ T SEIBERT K KHAN N ISAKSON P
Citation: S. Paulson et al., PRECLINICAL PHARMACOLOGY OF CELECOXIB AND DEMONSTRATION OF SUPERIOR GI SAFETY COMPARED WITH NSAIDS IN DOGS, The FASEB journal, 12(5), 1998, pp. 4408-4408
CELECOXIB - A SPECIFIC COX-2 INHIBITOR WITH ANTIINFLAMMATORY, ANALGESIC AND ANTICANCER ACTIVITIES
Authors: MASFERRER JL LEAHY K KOBOLT C PERKINS W ZWEIFEL B ZHANG Y KOKI A ISAKSON P SEIBERT K
Citation: Jl. Masferrer et al., CELECOXIB - A SPECIFIC COX-2 INHIBITOR WITH ANTIINFLAMMATORY, ANALGESIC AND ANTICANCER ACTIVITIES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 43-43
INHIBITION OF HUMAN COLON-CANCER CELL-GROWTH BY SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2
Authors: SHENG HM SHAO JY KIRKLAND SC ISAKSON P COFFEY RJ MORROW J BEAUCHAMP RD DUBOIS RN
Citation: Hm. Sheng et al., INHIBITION OF HUMAN COLON-CANCER CELL-GROWTH BY SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2, The Journal of clinical investigation, 99(9), 1997, pp. 2254-2259
ANALGESIC EFFICACY AND PLASMA-LEVELS OF A HIGHLY SELECTIVE INHIBITOR OF COX-2 (SC-58635-SC) IN PATIENTS WITH POSTSURGICAL DENTAL PAIN
Authors: MEHLISCH DR HUBBARD RC ISAKSON P KARIM A WEAVER M MILLS S
Citation: Dr. Mehlisch et al., ANALGESIC EFFICACY AND PLASMA-LEVELS OF A HIGHLY SELECTIVE INHIBITOR OF COX-2 (SC-58635-SC) IN PATIENTS WITH POSTSURGICAL DENTAL PAIN, Clinical pharmacology and therapeutics, 61(2), 1997, p.
PRECLINICAL PHARMACOLOGY OF CELECOXIB AND DEMONSTRATION OF SUPERIOR GI SAFETY COMPARED WITH NSAIDS IN DOGS
Authors: MAZIASZ T SEIBERT K KHAN N PAULSON S ISAKSON P
Citation: T. Maziasz et al., PRECLINICAL PHARMACOLOGY OF CELECOXIB AND DEMONSTRATION OF SUPERIOR GI SAFETY COMPARED WITH NSAIDS IN DOGS, Arthritis and rheumatism, 40(9), 1997, pp. 983-983
COX-2, A SYNAPTICALLY INDUCED ENZYME, IS EXPRESSED BY EXCITATORY NEURONS AT POSTSYNAPTIC SITES IN RAT CEREBRAL-CORTEX
Authors: KAUFMANN WE WORLEY PF PEGG J BREMER M ISAKSON P
Citation: We. Kaufmann et al., COX-2, A SYNAPTICALLY INDUCED ENZYME, IS EXPRESSED BY EXCITATORY NEURONS AT POSTSYNAPTIC SITES IN RAT CEREBRAL-CORTEX, Proceedings of the National Academy of Sciences of the United Statesof America, 93(6), 1996, pp. 2317-2321
MECHANISM OF DIFFERENTIAL INHIBITION OF THE INDUCIBLE AND CONSTITUTIVE FORMS OF CYCLOOXYGENASE
Authors: GIERSE J ASKONAS L SEIBERT K ISAKSON P
Citation: J. Gierse et al., MECHANISM OF DIFFERENTIAL INHIBITION OF THE INDUCIBLE AND CONSTITUTIVE FORMS OF CYCLOOXYGENASE, The FASEB journal, 9(6), 1995, pp. 1372-1372
ANTIINFLAMMATORY EFFECTS OF SECOND-GENERATION LEUKOTRIENE-B-4 RECEPTOR ANTAGONIST, SC-53228 - IMPACT UPON LEUKOTRIENE-B-4-MEDIATED AND 12(R)-HETE-MEDIATED EVENTS
Authors: FRETLAND DJ ANGLIN CP BREMER M ISAKSON P WIDOMSKI DL PAULSON SK DOCTER SH DJURIC SW PENNING TD YU S MCKEARN JP
Citation: Dj. Fretland et al., ANTIINFLAMMATORY EFFECTS OF SECOND-GENERATION LEUKOTRIENE-B-4 RECEPTOR ANTAGONIST, SC-53228 - IMPACT UPON LEUKOTRIENE-B-4-MEDIATED AND 12(R)-HETE-MEDIATED EVENTS, Inflammation, 19(2), 1995, pp. 193-205
PHARMACOLOGICAL INHIBITION OF COX-2 PREVENTS ELCOSANOID PRODUCTION AND EDEMA IN-VIVO
Authors: ZHANG Y SEIBERT K HAUSER S GREGORY S ISAKSON P
Citation: Y. Zhang et al., PHARMACOLOGICAL INHIBITION OF COX-2 PREVENTS ELCOSANOID PRODUCTION AND EDEMA IN-VIVO, The FASEB journal, 8(4), 1994, pp. 10000410-10000410
CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TO MOUSE COX-2
Authors: BREMER M PEGG J GIERSE J ISAKSON P
Citation: M. Bremer et al., CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TO MOUSE COX-2, The FASEB journal, 8(4), 1994, pp. 10000411-10000411
ANTIBODY-BINDING TO THE JUXTAMEMBRANE REGION OF THE INSULIN-RECEPTOR ALTERS RECEPTOR AFFINITY
Authors: GOODMAN DW ROMERO G ISAKSON P
Citation: Dw. Goodman et al., ANTIBODY-BINDING TO THE JUXTAMEMBRANE REGION OF THE INSULIN-RECEPTOR ALTERS RECEPTOR AFFINITY, Journal of receptor research, 14(6-8), 1994, pp. 381-398
PHARMACOLOGICAL AND BIOCHEMICAL DEMONSTRATION OF THE ROLE OF CYCLOOXYGENASE-2 IN INFLAMMATION AND PAIN
Authors: SEIBERT K ZHANG Y LEAHY K HAUSER S MASFERRER J PERKINS W LEE L ISAKSON P
Citation: K. Seibert et al., PHARMACOLOGICAL AND BIOCHEMICAL DEMONSTRATION OF THE ROLE OF CYCLOOXYGENASE-2 IN INFLAMMATION AND PAIN, Proceedings of the National Academy of Sciences of the United Statesof America, 91(25), 1994, pp. 12013-12017
Risultati: 1-13 |